Bringing healthcare innovations to market takes strategy, resilience, and adaptability. In this online seminar, a panel of experienced health and medical innovators will share how they have navigated the journey from early ideas to real-world impact. Designed for early-stage innovators, the discussion offers practical insights, key lessons and candid advice to help you clarify your goals, anticipate challenges and plan your next steps.

Panelists include Luiz E. Bertassoni, D.D.S., Ph.D., founding director of the Knight Cancer Precision Biofabrication Hub and professor at the division of oncological sciences, and professor in the department of oral rehabilitation and integrative biosciences in the School of Dentistry,  Rachel Dreilinger, co-founder and CEO of NeuraMedica , and Philippe Marchand, Ph.D., program director in OHSU Cancer Early Detection Advanced Research Center in the OHSU Knight Cancer Institute.

Part of the Biomedical Innovation Commercialization Readiness Program (BIP Corp), this session is free and open to all

Register for this event through Zoom.